Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306292 · ClinicalTrials.gov registry record · Phase 2
Safety of SonoVue on Pulmonary Hemodynamics
A Phase 2 study, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT01306292 is a Phase 2 study that has completed, run by Bracco Diagnostics. The registered enrollment target is 36 participants.
The verdict
NCT01306292, a Phase 2 study, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is an intra-subject crossover comparative safety study to evaluate the effect of intravenous (IV) bolus injection of SonoVue on pulmonary hemodynamics.
Interventions
- DRUG Placebo
- DRUG SonoVue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01306292
The ClinicalTrials.gov registry entry for NCT01306292 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bracco Diagnostics, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01306292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01306292 about?
NCT01306292 is a clinical study titled "Safety of SonoVue on Pulmonary Hemodynamics". This is an intra-subject crossover comparative safety study to evaluate the effect of intravenous (IV) bolus injection of SonoVue on pulmonary hemodynamics.
What is the current status of trial NCT01306292?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2011-04. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01306292?
The interventions under investigation include: Placebo (DRUG), SonoVue (DRUG).
Who is sponsoring clinical trial NCT01306292?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.